Kano S, Kawakita D, Honma Y, Takahashi H, et al. The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy. Oral Oncol 2025;165:107280.
PMID: 40252453